UPDATE : Monday, September 7, 2020
상단여백
[Exclusive] Samsung admits it failed to develop Rituxan biosimilar
The Samsung Group has admitted that a Samsung-affiliated company failed to ...
by Jeong Sae-im  |  2019-10-16 14:16
라인
Eulji Medical Center transfers advanced medical expertise to Bangladesh
Eulji Medical Center (EMC) said Wednesday that it would provide invitation ...
by Lee Han-soo  |  2019-10-16 11:28
라인
Seoul Medical Center transfer public healthcare know-how to developing countries
Seoul Medical Center (SMC) is speeding up the transfer of "Seoul-model publ...
by Lee Han-soo  |  2019-10-15 18:02
라인
‘Genome analysis-based therapy to help realize precision medicine’
Samsung Medical Center has become the world’s first hospital to demonstrate...
by Lee Han-soo  |  2019-10-15 17:50
라인
'High ozone levels can aggravate dry eye symptoms'
A research team at Gacheon University Gil Medical Center has found that hig...
by Lee Han-soo  |  2019-10-15 17:50
라인
Merck Korea forcefully shuts down general medicine biz
Merck Biopharma Korea said it would complete shutting down the General Medi...
by Kim Yun-mi  |  2019-10-15 15:51
라인
Galderma Korea’s key strategy: choice and concentration
Galderma recently debuted as the world’s largest independent dermatology co...
by Kim Yun-mi  |  2019-10-15 13:56
라인
Korea brings up Fukushima’s radioactive water disposal issue at WHO
The Ministry of Health and Welfare said that it conveyed the Korean governm...
by Lee Han-soo  |  2019-10-15 12:54
라인
Medytox, Daewoong still in dispute over Nabota's spore appraisal
Medytox and Daewoong Pharmaceutical continued to brawl over the origin of t...
by Lee Han-soo  |  2019-10-15 11:28
라인
Kolon Life Science shares surge after TissueGene’s survival
Shares of Kolon Life Science shot up after the regulator decided to delay t...
by Jeong Sae-im  |  2019-10-14 18:01
라인
Lilly’s Taltz shows superiority to Tremfya in treating psoriasis patients
The Korean branch of Eli Lilly said it has presented the phase 4 IXORA-R st...
by Lee Han-soo  |  2019-10-14 18:01
라인
First lung disease reported here with suspected ties to vaping
The Korea Centers for Disease Control and Prevention (KCDC) said that it ha...
by Lee Han-soo  |  2019-10-14 18:01
라인
HLB merges with Elevar to own rivoceranib rights
HLB said it would merge with its subsidiary Elevar, a U.S.-based developer ...
by Jeong Sae-im  |  2019-10-14 14:43
라인
HanAll's Chinese partner ends P2 trial of dry eye treatment
HanAll Biopharma said that Harbour Biomed, its Chinese partner, has complet...
by Lee Han-soo  |  2019-10-14 14:08
라인
[Special] How are Korean employees coping with big-pharma M&As?
Since multinational pharmaceutical companies announced merger and acquisiti...
by Kim Yun-mi  |  2019-10-14 13:45
라인
Sanofi releases data showing improved survival for prostate cancer treatment
Sanofi said that it has published research results confirming a longer radi...
by Lee Han-soo  |  2019-10-14 12:16
라인
Regulator keeps Kolon Tissuegene listed with 1-year grace period
The Korean Exchange (KRX) decided to keep Kolon Tissuegene listed on the Ko...
by Lee Han-soo  |  2019-10-12 09:41
라인
GC to market Merck's diabetes treatment
Merck Biopharma Korea said that GC would market Glucophage, its diabetes tr...
by Lee Han-soo  |  2019-10-11 18:13
라인
Bayer drugs out of stock in Korea
Bayer is having trouble supplying its drug in the local market as the compa...
by Lee Han-soo  |  2019-10-11 16:36
라인
Drug regulator to hire 87 more reviewers next year
The Ministry of Food and Drug Safety said it would add 87 staff for the rev...
by Lee Hye-seon  |  2019-10-11 16:35
여백
여백
여백
Back to Top